Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor
暂无分享,去创建一个
M. Monden | K. Dono | H. Nagano | K. Umeshita | Y. Fujiwara | Hirofumi Yamamoto | N. Hiraoka | M. Sakon | S. Nakamori | M. Tsujie | N. Hayashi | J. Okami
[1] A. Folsom,et al. Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. , 2002, Journal of the National Cancer Institute.
[2] N. Shinomiya,et al. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines. , 2000, Anticancer research.
[3] R. Makuch,et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.
[4] B. Levin,et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.
[5] C. Compton,et al. Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control. , 2000, Annals of surgery.
[6] A. Hsu,et al. The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2* , 2000, The Journal of Biological Chemistry.
[7] D. Heilman,et al. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. , 2000, Carcinogenesis.
[8] F. Sinicrope,et al. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. , 1999, Cancer research.
[9] M. Monden,et al. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] M. Imamura,et al. Characterization of six cell lines established from human pancreatic adenocarcinomas , 1999, Cancer.
[11] M. Matsushita,et al. Profile of JTE-522 as a human cyclooxygenase-2 inhibitor. , 1998, Japanese journal of pharmacology.
[12] R. DuBois,et al. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.
[13] S. Arii,et al. Involvement of matrix metalloproteinase‐2 activity in invasion and metastasis of pancreatic carcinoma , 1998, Cancer.
[14] K. Seibert,et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. , 1998, Cancer research.
[15] T. Tanaka,et al. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats , 1997, Inflammation Research.
[16] C. Paraskeva,et al. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] R. DuBois,et al. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Coffey,et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.
[19] J. Morrow,et al. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. , 1994, The Journal of clinical investigation.
[20] R. Hardman,et al. Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. , 1993, Archives of biochemistry and biophysics.
[21] David A Jones,et al. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. , 1993, The Journal of biological chemistry.
[22] T. Hla,et al. Human cyclooxygenase-2 cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[23] E. Kohn,et al. Cancer invasion and metastases. , 1990, JAMA.
[24] Y Iwamoto,et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.
[25] C. Rüegg,et al. NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. , 2001, Nature medicine.
[26] H. Friess,et al. Role of MT‐MMPs and MMP‐2 in pancreatic cancer progression , 2000, International journal of cancer.
[27] K. Schrör,et al. Cyclooxygenase-2 expression in human esophageal carcinoma. , 1999, Cancer research.
[28] Taylor Murray,et al. Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.
[29] L. Liotta,et al. Tumor cell interactions with the extracellular matrix during invasion and metastasis. , 1993, Annual review of cell biology.